Exact Mass: 407.1746016
Exact Mass Matches: 407.1746016
Found 168 metabolites which its exact mass value is equals to given mass value 407.1746016
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Methyl Erlotinib Hydrochloride
Dibutyryl adenosine
n6,2'-o-dibutyryladenosine
PDE-4 Inhibitors
C17H29NO10_2-{[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-3-methylbutanenitrile
Ala Cys Lys Ser
C15H29N5O6S (407.18384540000005)
Ala Cys Ser Lys
C15H29N5O6S (407.18384540000005)
Ala Phe Gly Asn
Ala Phe Asn Gly
Ala Gly Phe Asn
Ala Gly Asn Phe
Ala Lys Cys Ser
C15H29N5O6S (407.18384540000005)
Ala Lys Ser Cys
C15H29N5O6S (407.18384540000005)
Ala Asn Phe Gly
Ala Asn Gly Phe
Ala Ser Cys Lys
C15H29N5O6S (407.18384540000005)
Ala Ser Lys Cys
C15H29N5O6S (407.18384540000005)
Cys Ala Lys Ser
C15H29N5O6S (407.18384540000005)
Cys Ala Ser Lys
C15H29N5O6S (407.18384540000005)
Cys Gly Lys Thr
C15H29N5O6S (407.18384540000005)
Cys Gly Thr Lys
C15H29N5O6S (407.18384540000005)
Cys Lys Ala Ser
C15H29N5O6S (407.18384540000005)
Cys Lys Gly Thr
C15H29N5O6S (407.18384540000005)
Cys Lys Ser Ala
C15H29N5O6S (407.18384540000005)
Cys Lys Thr Gly
C15H29N5O6S (407.18384540000005)
Cys Ser Ala Lys
C15H29N5O6S (407.18384540000005)
Cys Ser Lys Ala
C15H29N5O6S (407.18384540000005)
Cys Thr Gly Lys
C15H29N5O6S (407.18384540000005)
Cys Thr Lys Gly
C15H29N5O6S (407.18384540000005)
Phe Ala Gly Asn
Phe Ala Asn Gly
Phe Gly Ala Asn
Phe Gly Gly Gln
Phe Gly Asn Ala
Phe Gly Gln Gly
Phe Asn Ala Gly
Phe Asn Gly Ala
Phe Gln Gly Gly
Gly Ala Phe Asn
Gly Ala Asn Phe
Gly Cys Lys Thr
C15H29N5O6S (407.18384540000005)
Gly Cys Thr Lys
C15H29N5O6S (407.18384540000005)
Gly Phe Ala Asn
Gly Phe Gly Gln
Gly Phe Asn Ala
Gly Phe Gln Gly
Gly Gly Phe Gln
Gly Gly Gln Phe
Gly Lys Cys Thr
C15H29N5O6S (407.18384540000005)
Gly Lys Thr Cys
C15H29N5O6S (407.18384540000005)
Gly Asn Ala Phe
Gly Asn Phe Ala
Gly Gln Phe Gly
Gly Gln Gly Phe
Gly Thr Cys Lys
C15H29N5O6S (407.18384540000005)
Gly Thr Lys Cys
C15H29N5O6S (407.18384540000005)
Lys Ala Cys Ser
C15H29N5O6S (407.18384540000005)
Lys Ala Ser Cys
C15H29N5O6S (407.18384540000005)
Lys Cys Ala Ser
C15H29N5O6S (407.18384540000005)
Lys Cys Gly Thr
C15H29N5O6S (407.18384540000005)
Lys Cys Ser Ala
C15H29N5O6S (407.18384540000005)
Lys Cys Thr Gly
C15H29N5O6S (407.18384540000005)
Lys Gly Cys Thr
C15H29N5O6S (407.18384540000005)
Lys Gly Thr Cys
C15H29N5O6S (407.18384540000005)
Lys Ser Ala Cys
C15H29N5O6S (407.18384540000005)
Lys Ser Cys Ala
C15H29N5O6S (407.18384540000005)
Lys Thr Cys Gly
C15H29N5O6S (407.18384540000005)
Lys Thr Gly Cys
C15H29N5O6S (407.18384540000005)
Asn Ala Phe Gly
Asn Ala Gly Phe
Asn Phe Ala Gly
Asn Phe Gly Ala
Asn Gly Ala Phe
Asn Gly Phe Ala
Asn Ser Ser Thr
Asn Ser Thr Ser
Asn Thr Ser Ser
Gln Phe Gly Gly
Gln Gly Phe Gly
Gln Gly Gly Phe
Gln Ser Ser Ser
Ser Ala Cys Lys
C15H29N5O6S (407.18384540000005)
Ser Ala Lys Cys
C15H29N5O6S (407.18384540000005)
Ser Cys Ala Lys
C15H29N5O6S (407.18384540000005)
Ser Cys Lys Ala
C15H29N5O6S (407.18384540000005)
Ser Lys Ala Cys
C15H29N5O6S (407.18384540000005)
Ser Lys Cys Ala
C15H29N5O6S (407.18384540000005)
Ser Asn Ser Thr
Ser Asn Thr Ser
Ser Gln Ser Ser
Ser Ser Asn Thr
Ser Ser Gln Ser
Ser Ser Ser Gln
Ser Ser Thr Asn
Ser Thr Asn Ser
Ser Thr Ser Asn
Thr Cys Gly Lys
C15H29N5O6S (407.18384540000005)
Thr Cys Lys Gly
C15H29N5O6S (407.18384540000005)
Thr Gly Cys Lys
C15H29N5O6S (407.18384540000005)
Thr Gly Lys Cys
C15H29N5O6S (407.18384540000005)
Thr Lys Cys Gly
C15H29N5O6S (407.18384540000005)
Thr Lys Gly Cys
C15H29N5O6S (407.18384540000005)
Thr Asn Ser Ser
Thr Ser Asn Ser
Thr Ser Ser Asn
MK-2206
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(2S,3R)-BENZYL 3-METHYL-2-(METHYLAMINO)PENTANOATE 4-METHYLBENZENESULFONATE
C21H29NO5S (407.17663440000007)
Methanone, [4-(3,5-dimethoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-
Ciforadenant
C308 - Immunotherapeutic Agent > C2139 - Immunostimulant Ciforadenant (CPI-444) is a potent, orally active and selective adenosine A2A receptor (A2AR) antagonist, which induces antitumor responses[1].
[(2S,3S)-2-[(1S)-1-hydroxy-2-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-2-oxoethyl]-5-oxooxolan-3-yl]azanium
(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]-4-methylpentanoic acid
C16H30N3O7P (407.18212800000003)
5-[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-5-hydroxynonane-4,6-dione
[2-(1-Piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone
[5-[(2-Methoxyphenoxy)methyl]-3-isoxazolyl]-(4-methyl-3-phenyl-1-piperazinyl)methanone
4-{[6-Endo-amino-6-exo-benzoyl-5-exo-phenylnorbornan-2-yl]oxy}-4-oxobutanoic acid
9-(1,3-Benzodioxol-5-yl)-6,7-dimethoxy-3,3-dimethyl-2,4,9,9a-tetrahydroacridin-1-one
N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-D-galactosaminyl group
An N-acetyl-D-galactosaminyl group obtained by removing the hydroxy group from the hemiacetal function of N-acetyl-beta-D-glucosaminyl-1,3-N-acetyl-D-galactosamine.
N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group
N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-D-galactosaminyl group with alpha-configuration at the reducing-end anomeric centre.